DexCom's new sensor model and Medicare expansion boost long-term growth potential.

DexCom, a healthcare tech company specializing in continuous glucose monitoring sensors, benefits from expanded Medicare coverage that could increase its market size. The company now offers longer-wear sensors and plans to scale up manufacturing, which may improve profit margins. These developments position DexCom as a strong long-term buy for investors betting on wider patient adoption of its diabetes management technology.

DexCom shares trade at USD 82.24 on Pluang as of Nov 02, 2026 11:41 WIB, up 4.60% in one day. The stock's market cap stands at $30.70 billion, reflecting strong investor interest. Volume reached 8,637,191 shares, with a typical hold time of 63 days on the platform.